Should probably point to https://neurosciencenews.com/vaccine-alzheimers-23722/
Technology
This is the official technology community of Lemmy.ml for all news related to creation and use of technology, and to facilitate civil, meaningful discussion around it.
Ask in DM before posting product reviews or ads. All such posts otherwise are subject to removal.
Rules:
1: All Lemmy rules apply
2: Do not post low effort posts
3: NEVER post naziped*gore stuff
4: Always post article URLs or their archived version URLs as sources, NOT screenshots. Help the blind users.
5: personal rants of Big Tech CEOs like Elon Musk are unwelcome (does not include posts about their companies affecting wide range of people)
6: no advertisement posts unless verified as legitimate and non-exploitative/non-consumerist
7: crypto related posts, unless essential, are disallowed
TL;DR: Looks promising in mice, not tested in humans yet.
Slightly longer AI summary by Kagi
Researchers have developed a novel vaccine that targets senescence-associated glycoprotein (SAGP) expressed in inflamed brain cells linked to Alzheimer's disease. When tested in mice, the vaccine reduced amyloid deposits, decreased inflammatory biomarkers, and improved the animals' awareness of their surroundings. This suggests the vaccine may lessen disease symptoms. The vaccine targets activated microglia cells which play a role in brain inflammation that can worsen cognitive decline. By removing toxic microglia, the vaccine may control inflammation and ultimately repair deficits suffered in Alzheimer's disease. If successful in humans, the vaccine could be a major step forward in delaying or preventing the disease.